[Discussion] pharmacy is doing more work than we give it credit for
Something I noticed reading old threads that I have not seen said out loud.
The advice on tier 3 in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the same confidence.
I have listed what I think the current consensus is below. Correct me — that is the point of posting it.
best — the order this archive was captured in
Boots stock is hit-and-miss by location
Removed a chain here. The rule is one line long and it is not negotiable.
Boots stock check: called 3 locations in Germany, 29 had 5mg in stock. Regional variation is real.
Boots stock check: called 3 locations in Germany, 29 had 5mg in stock.
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
The tier 3 pathway in my area: 6 month wait, then 28 months for review, then approved. Total UK.
say which nation, England, Scotland, Wales, NI differ
[removed by moderator]
private prescription routes vary by region
price posts need the date — UK pricing moves monthly
That is net peptide content, not purity. Different number, different meaning.
pharmacy stock is pricing, check before traveling
MHRA supply notices change monthly, follow the actual list
the Scottish pathway is different from the English one
say which nation, England, Scotland, Wales, NI differ
This is correct. Private and NHS pathways are different.
- 1The tier 3 pathway in my area: 6 month wait, then 28 months for review, then…10 comments in this branch · started by u/marisol_moreau